Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE5A | O76074 | 17/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.66 |
| ▸ | MEN1 | O00255 | 1/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.66 |
| ▸ | HPGD | P15428 | 1/20 | 0.66 |
| ▸ | PDE1A | P54750 | 1/20 | 0.66 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.66 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.66 |
| ▸ | PDE3B | Q13370 | 2/20 | 0.59 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.59 |
| ▸ | PDE6C | P51160 | 1/20 | 0.47 |
| ▸ | PDE4A | P27815 | 2/20 | 0.47 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.47 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.47 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5462416 | 0.95 | PDE5A (0.67) | PDE5AKMT2AMEN1ALDH1A1HPGD | |
| SCHEMBL5453341 | 0.92 | PDE5A (0.77) | PDE5AKMT2AMEN1ALDH1A1HPGD | |
| SCHEMBL6715674 | 0.90 | PDE5A (0.61) | PDE5AKMT2AMEN1ALDH1A1HPGD | |
| SCHEMBL5445759 | 0.89 | PDE5A (0.63) | PDE5AKMT2AMEN1ALDH1A1HPGD | |
| SCHEMBL6716572 | 0.88 | PDE5A (0.63) | PDE5AKMT2AMEN1ALDH1A1HPGD | |
| SCHEMBL6718781 | 0.88 | PDE5A (0.85) | PDE5AKMT2AMEN1ALDH1A1HPGD | |
| SCHEMBL6713800 | 0.82 | KMT2A (0.61) | PDE5AKMT2APDE1APDE1BPDE1C | |
| SCHEMBL31202656 | 0.82 | PDE5A (0.86) | PDE5AKMT2AMEN1ALDH1A1HPGD | |
| SCHEMBL799 | 0.82 | PDE5A (0.86) | PDE5AKMT2AMEN1ALDH1A1HPGD | |
| SCHEMBL5459779 | 0.80 | PDE5A (0.64) | PDE5AKMT2AMEN1ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040176371-A1 | Novel pyrazolopyrimidinethione derivatives, preparation methods thereof and their use as therapeutics for erectile dysfunction | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2004-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040176371-A1 | Novel pyrazolopyrimidinethione derivatives, preparation methods thereof and their use as therapeutics for erectile dysfunction | PDE3B, PDE3A, PDE5A | PDE5A 3/4885KMT2A 4233/4885MEN1 4650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.